Davies et al. demonstrate that androgen receptor–targeted therapy induces lineage-plastic transcriptional reprogramming, which is mediated by EZH2 and favours stem cell and neuronal gene networks in treatment-resistant prostate cancer.
- Alastair Davies
- Shaghayegh Nouruzi
- Amina Zoubeidi
